Alignment Healthcare, Inc. · Hospital & Medical Service Plans

ALHC

Moderate riskNext report: In 1 days (est.)

View price ↗

The short version

A company still losing money with growing sales. Institutions are adding.

Going well

Sales up 32% in the latest quarter vs a year ago
Sales up 46% last year

Watch out for

Losing money
Debt above equity: 1.8x

Money moves

Insiders sold $270K in the last 30 days
Institutions added 10% to their holdings in the quarter ending June 2026 (218 bought, 125 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$7.88-2.4% that day

Company value: $1.6B; Share price times all shares
Price vs profit (P/E): 41.5x; You pay about $41 for each $1 of yearly profit
Price vs sales: 0.36x; Company value is 0.36 times a year of sales
Cash vs value: 42%; A big cushion: cash is a large part of what the company is worth
Debt vs value: 20%; Debt as a share of company value

From ALHC's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$1.3B+32% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $4.6B, up 37% from the 12 months before. Over 5 years, sales grew about 33% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of ALHC. Starting points are the company's recent numbers.

Sales growth+30% a yearRecently: +37% a yearProfit margin1%Last 12 months: 0.9%P/E at the end40xToday: 41.5x. Many steady companies trade at 12x to 25xShare count change+3% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$17.0B

Profit in 5 years$170M

Price these guesses point to$28.27+259% vs $7.88 todayAbout +29% a year, before dividends

What today's price needs: with a 1% margin and a 40x P/E, sales would have to grow about 0.7% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

1/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-0.5%
MissDebt under half of equityNot relying on borrowed money.1.80x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.0.0%
MissProfitable every yearSteady profits, not one good year.0 of 7 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$113.1M
MissShare count not growingNot diluting owners. Falling means buybacks.+9.3% in 3 years

Revenue: $3.9B; +46.1% vs prior year
5-year growth: +32.7%/yr; revenue, per year
Total debt: $323.2M; 1.80x equity
Current ratio: 1.71x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.